Plain-English translation of NCT07536529 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are investigating how oxidative stress—a chemical imbalance in the body caused by harmful molecules called free radicals—affects autoimmune rheumatic diseases like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. By studying blood samples and health records from 200 adults with these conditions, scientists hope to better understand how oxidative stress influences disease severity and progression, which could lead to improved treatments and prevention strategies.
Current treatments for autoimmune joint diseases don't work equally well for everyone, and some patients experience serious side effects. Researchers believe that oxidative stress plays an important role in these diseases, but we don't yet fully understand how it affects each patient differently. This study aims to fill that knowledge gap so doctors can develop more personalized and effective treatment plans.
You likely qualify if…
You likely don't qualify if…
This is an observational study, meaning you will not receive any new medication or treatment. Instead, you'll have blood drawn to measure oxidative stress markers, and researchers will review your medical history and current health status. The study involves minimal burden—primarily a one-time or occasional blood draw and permission for the research team to access your medical records to track your disease over time.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Greece